Joint safety alert issued surrounding appropriate HRT dosage

A joint safety alert has been issued from the British Menopause Society, Faculty of Sexual & Reproductive Healthcare, Royal College of General Practitioners, Royal College of Obstetricians & Gynaecologists, Society for Endocrinology and the Royal College of Nursing Women’s Health Forum.

This safety alert has been produced in response to questions raised in relation to appropriate doses of oestrogen and progestogen provided to women experiencing symptoms of menopause.

Current National Institute for Health and Care Excellence (NICE), MHRA and national and international guidance recommends the lowest effective dose to control symptoms, but an increasing numbers of women are being initiated on high doses of oestrogen which exceed the product licenses, not in line with any clinical guidelines.

Read the alert in full.